Eva Tiecke News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eva Tiecke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eva Tiecke Today - Breaking & Trending Today

Novaremed AG: Novaremed's Non-opioid Lead Compound, NRD.E1, to be Tested in NIH HEAL Initiative Phase 2 Trial for the Treatment of Chronic Pain

Published: December 21, 2021

NIH, through the Helping to End Addiction Long-term Initiative, to sponsor the Phase 2b SERENDIPITY-1 study, evaluating NRD.E1 in patients with painful diabetic peripheral neuropathy (PDPN)

Source: finanznachrichten.de

Related Topics:

United StatesMark AltmeyerKostenloser WertpapierhandelEva TieckeIsaac KobrinEarly Phase Pain Investigation Clinical NetworkMetys Pharmaceuticals Ag SwitzerlandEnd Addiction InitiativeNovaremed Ltd IsraelNational Institutes Of HealthUs National Institutes Of HealthEnd Addiction Long Term InitiativeNational InstitutesExecutive ChairmanChief Scientific OfficerFast Track DesignationPainful Diabetic Peripheral NeuropathyRandomised ProofConcept StudyEuropean JournalTrack DesignationMetys PharmaceuticalsExecutive Member

Novaremed's Non-opioid Lead Compound, NRD.E1, to be Tested in NIH HEAL Initiative Phase 2 Trial for the Treatment of Chronic Pain

Published: December 21, 2021

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com

Related Topics:

United StatesMark AltmeyerEva TieckeIsaac KobrinEarly Phase Pain Investigation Clinical NetworkMetys Pharmaceuticals Ag SwitzerlandNovaremed Ltd IsraelNational Institutes Of HealthUs National Institutes Of HealthNational InstitutesExecutive ChairmanChief Scientific OfficerFast Track DesignationPainful Diabetic Peripheral NeuropathyRandomised ProofConcept StudyEuropean JournalTrack DesignationMetys PharmaceuticalsExecutive MemberBusiness WireChronic Pain